the sun malaysia ipaper logo 150x150
Tuesday, June 23, 2026
21.4 C
Malaysia
the sun malaysia ipaper logo 150x150

S.Korea probing two deaths after AstraZeneca’s Covid-19 vaccine

SEOUL: South Korean authorities said today they are investigating the deaths of two people after a media report said the pair ― both with pre-existing conditions ― died within days of receiving AstraZeneca’s Covid-19 vaccine.

A 63-year-old nursing home patient with cerebrovascular disease developed symptoms, including high fever, after being given the AstraZeneca vaccine, Yonhap news agency reported. The person was moved to a larger hospital yesterday, but died after showing symptoms of blood poisoning and pneumonia, Yonhap said.

Another person in their 50s with a cardiac disorder and diabetes died today after suffering multiple heart attacks, having received the same vaccine a day earlier, the agency said.

An official with the Korea Disease Control and Prevention Agency (KDCA) told Reuters it was investigating the cause of the deaths, but did not elaborate or confirm the details of Yonhap’s report.

An AstraZeneca spokeswoman in Seoul said the company had no comment at present.

South Korea began vaccinating its population last week. By yesterday midnight, 85,904 people had received first doses of the AstraZeneca vaccine and 1,524 had been given Pfizer shots, KDCA said in a statement.

South Korea reported 444 new confirmed Covid-19 cases yesterday, up from 344 on Monday, raising the country’s tally to 90,816 infections, with 1,612 deaths. ― Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

AS Watson Launches brand lab to Turn Retail Scale into a Data-driven Brand Growth...

HONG KONG SAR - Media OutReach Newswire - 22 June 2026 - AS Watson Group has launched AS Watson brand lab, a data-driven brand creation and scaling platform designed to systematically identify, develop, and grow brands across its global retail ecosystem.

Ucore Produces NdPr Oxide and Ships Qualification Samples to Major Rare Earth Magnet Manufacturers

Halifax, Nova Scotia--(Newsfile Corp. - June 22, 2026) - Ucore Rare Metals Inc.(TSXV: UCU) (OTCQX: UURAF) ("Ucore" or the "Company") is pleased to announce that it has produced commercial-grade neodymium-praseodymium ("NdPr") oxide and shipped initial qualification samples to major rare earth permanent magnet manufacturers for technical evaluation.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings